MedPath

Reduction of cetrorelix dose in the antagonist multiple dose protocol and its impact on pregnancy rate and economic aspect. A randomized controlled study

Not Applicable
Conditions
recruitong
Registration Number
JPRN-UMIN000027193
Lead Sponsor
Tanta university Obstetrics and gynecology department
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Severe endometriosis Previous IVF/ICSI failure Severe male factor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of ova retreived, quality of ooocytes
Secondary Outcome Measures
NameTimeMethod
umber of embryos , clinical and ongoing pregnancy rates, and economic aspects of reducing cetrorelix dose.
© Copyright 2025. All Rights Reserved by MedPath